Cochlear Limited (ASX:COH) develops implantable hearing solutions for people with severe to profound hearing loss. The company operates a global healthcare technologyBusinesssupported by cochlear implant systems, services and acoustic products. During FY2026, Cochlear continued progressing its Nucleus Nexa System while managing changing market conditions …
Audeara Limited (ASX:AUA) is an Australian hearing technology company developing personalised audio products and hearing-health solutions. During 2026, the company continued building commercial relationships across Australia and international markets while progressing product distribution and technology licensing opportunities.
Fast Track is designed to facilitate development and potentially expedite review for therapies or products addressing serious conditions and unmet medical needs. For BiPASS, the designation may support closer FDA interaction, but it is not an approval. Use of Illuccix and Gozellix in the …
The lease is between a private Indonesian landowner and PT BPH Global Indonesia, a subsidiary of Ocean Sciences. It covers two adjoining parcels at Laikang Village, Mangarabombang District, Takalar Regency, totalling about 33,719 square metres, or 3.4 hectares. The site lies roughly 40 to …
Vitrafy Life Sciences Limited (ASX:VFY) is developing cryopreservation technologies designed to support the collection, preservation, storage and delivery of biological materials. The company’s shares were trading at AUD 3.760, up AUD 0.330 or 9.62% during the session. Vitrafy has announced a partnership with Versiti …
BREASTESTplus 2 uses an enhanced lipid biomarker panel for detecting early-stage breast cancer, covering Stage 0, Stage 1 and Stage 2. BCAL reported sensitivity of 80.3% and specificity of 48.5%. Of the breast cancers detected in the validation study, 61.9% were Stage 0 or …
The rollout starts with an upgrade of the ExtraMed Flow system at Salford Royal Hospital before extending to Royal Oldham Hospital, Fairfield General Hospital and Rochdale Infirmary. Miya Flow is built on Alcidion’s Miya Precision platform, which centralises information into dashboards and supports interoperability, …
FY2026 revenue increased from AUD 50.8 million to AUD 60.3 million. EBITDA rose to AUD 5.4 million from AUD 3.1 million, while net profit after tax reached AUD 0.3 million compared with a AUD 1.3 million loss in FY2025. EBITDAMarginincreased to 9% from 6%, …
The cash payment relates to eligible Australian research and development activities across AnteoTech’s Advanced Battery Technologies and Life ScienceBusinessunits during FY2026. The payment was received after the balance date and is therefore separate from the AUD 11.2 million held in the bank at 30 …
Cleo Diagnostics Ltd (ASX:COV) is an Australian medical technology company developing diagnostic solutions for ovarian cancer detection. The company’s shares were trading at AUD 0.30, up nearly 6% on 30 September 2026 at 1:16 pm. Cleo Diagnostics has announced the filing of two provisional …